Management of Incompletely Staged Endometrial Carcinoma: A Case-Based Review

Muhammad Fakhmi, Andi Kurniadi


Abstract


Introduction: Endometrial carcinoma is the most common gynecologic malignancy in developed countries, driven by risk factors such as obesity and unopposed estrogen exposure. Early-stage detection is common due to early symptom onset. Surgical management remains the cornerstone of therapy and serves a dual role in staging the disease. This report presents the initial management of atypical endometrial hyperplasia, evaluation strategies, and treatment planning in a case of advanced-stage endometrial carcinoma with incomplete surgical staging.
Case Illustration: A 50-year-old woman presented with persistent vaginal discharge one week following a supracervical hysterectomy and bilateral salpingo-oophorectomy was referred to Hasan Sadikin Hospital Bandung performed for presumed benign disease. Histopathological and immunohistochemical evaluations confirmed the diagnosis of endometrioid adenocarcinoma of endometrial origin. Although chest imaging was negative for distant metastases, further evaluation suggested local extension consistent with FIGO Stage IIIB. Given the incomplete surgical staging and advanced local disease, the patient was referred for multimodal adjuvant therapy consisting of External Beam Radiotherapy (EBRT) and vaginal brachytherapy.
Conclusion: Total hysterectomy with bilateral salpingo-oophorectomy and appropriate surgical staging per FIGO guidelines represents the standard treatment for endometrial carcinoma. This case highlights that tailored adjuvant radiotherapy (EBRT and brachytherapy) is critical for effective disease management in incompletely staged high-grade or advanced-stage patients.

 

Abstrak
Pendahuluan: Karsinoma endometrium merupakan kanker ginekologi yang paling sering terjadi di negara-negara maju, dengan angka kejadian yang terus meningkat secara global. Faktor risiko utama meliputi obesitas, gangguan metabolik, serta paparan estrogen tanpa antagonis progesteron. Deteksi dini sering terjadi karena gejala muncul pada tahap awal penyakit. Penanganan bedah tetap menjadi pilar utama terapi dan sekaligus berperan dalam penentuan stadium penyakit. Laporan ini memaparkan tata laksana awal hiperplasia endometrium atipikal, strategi evaluasi, serta perencanaan terapi pada kasus karsinoma endometrium stadium lanjut dengan staging bedah yang tidak lengkap.
Ilustrasi Kasus: Seorang wanita berusia 50 tahun dengan diagnosis karsinoma endometrium dan riwayat histerektomi supraservikal serta salpingoovarektomi bilateral dirujuk ke Rumah Sakit Hasan Sadikin Bandung dengan keluhan keluarnya lendir berwarna kecokelatan dari vagina yang menetap satu minggu pascaoperasi. Pemeriksaan histopatologi dan imunohistokimia mengonfirmasi diagnosis adenokarsinoma endometrioid yang berasal dari endometrium. Tidak ditemukan metastasis pulmonal pada pemeriksaan radiologi. Pemeriksaan laboratorium menunjukkan anemia ringan, leukositosis, dan trombositosis. Diagnosis akhir yang ditegakkan adalah karsinoma endometrium suspek stadium IIIB menurut FIGO. Pasien kemudian dirujuk untuk menjalani radioterapi eksternal (EBRT) dan brakiterapi vagina sebagai terapi adjuvan.
Kesimpulan: Histerektomi total disertai salpingoovarektomi bilateral dan staging bedah yang sesuai dengan pedoman FIGO merupakan standar penatalaksanaan karsinoma endometrium. Terapi adjuvan seperti brakiterapi vagina dan EBRT berperan penting dalam penanganan kasus dengan staging yang tidak lengkap, seperti yang dijumpai pada pasien ini.

 


Keywords


Hysterectomy; endometrial carcinoma; management; radiotherapy

Full Text:

PDF

References


Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. The Lancet. Lancet Publishing Group; 2016 Mar 12;387(10023):1094–108

Lu KH, Broaddus RR. Endometrial Cancer. Longo DL, editor. New England Journal of Medicine. Massachusetts Medical Society; 2020 Nov 19;383(21):2053–64

eBioMedicine. Endometrial cancer: improving management among increasing incidence rates. EBioMedicine. Elsevier B.V.; 2024 May 1;103:105159

Endometrial cancer statistics | World Cancer Research Fund [Internet]. [cited 2025 Jun 1]. Available from: https://www.wcrf.org/preventing-cancer/cancer-statistics/endometrial-cancer-statistics/

Key Statistics for Endometrial Cancer | American Cancer Society | American Cancer Society [Internet]. [cited 2025 Jun 1]. Available from: https://www.cancer.org/cancer/types/endometrial-cancer/about/key-statistics.html?

Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, et al. Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin.American Cancer Society; 2019 Jul 1;69(4):258–79

Hermann C, Williams K, Ko EM. Endometrial Hyperplasia. Handbook of Gynecology, Second Edition [Internet]. StatPearls Publishing; 2024 Apr 30 [cited 2025 Jun 7];1029–47. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560693/

Uccella S, Zorzato PC, Dababou S, Bosco M, Torella M, Braga A, et al. Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women. Medicina (Lithuania) [Internet]. MDPI; 2022 Sep 1 [cited 2025 Jun 7];58(9). Available from: https://pubmed.ncbi.nlm.nih.gov/36143933/

Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: A gynecologic oncology group study. Cancer [Internet]. Cancer; 2006 Feb 15 [cited 2025 Jun 7];106(4):812–9. Available from: https://pubmed.ncbi.nlm.nih.gov/16400639/

Management of Endometrial Hyperplasia Green-top Guideline No. 67RCOG/BSGE Joint Guideline |. 2016

Passarello K, Kurian S, Villanueva V. Endometrial Cancer: An Overview of Pathophysiology, Management, and Care. Semin Oncol Nurs. W.B. Saunders; 2019 Apr 1;35(2):157–65

Alwafai Z, Beck MH, Fazeli S, Gürtler K, KunzYoung Academy of Gynecologic Oncology C, Singhartinger J, et al. Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO. BMC Cancer. BioMed Central Ltd; 2024 Dec 1;24(1)

Anca-Stanciu MB, Manu A, Olinca MV, Coroleucă C, Comandașu DE, Coroleuca CA, et al. Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes. Journal of Clinical Medicine 2025, Vol 14, Page 1385. Multidisciplinary Digital Publishing Institute; 2025 Feb 19;14(4):1385

Hoffman BL. Williams Gynecology. 3rd ed. Mc Graw Hill Education; 2012. p. 702–20

Mahdy H, Vadakekut ES, Crotzer D. Endometrial Cancer. StatPearls [Internet]. StatPearls Publishing; 2024 Apr 20 [cited 2025 Jun 4]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK525981/

Zhao X, Sun F, Leng N, Zhang X, Zhu Y. The past, present, and future of FIGO staging of endometrial cancer. J Gynecol Oncol [Internet]. J Gynecol Oncol; 2025 [cited 2025 Jun 1];36. Available from: https://pubmed.ncbi.nlm.nih.gov/40350708/

Galant N, Krawczyk P, Monist M, Obara A, Gajek Ł, Grenda A, et al. Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection. Int J Mol Sci. Multidisciplinary Digital Publishing Institute (MDPI); 2024 Jun 1;25(11)

Monk BJ, Berman ML, Montz FJ. Adhesions after extensive gynecologic surgery: Clinical significance, etiology, and prevention. Am J Obstet Gynecol [Internet]. Am J Obstet Gynecol; 1994 [cited 2025 Jun 12];170(5):1396–403. Available from: https://pubmed.ncbi.nlm.nih.gov/8178880/

Matsuo K, Machida H, Takiuchi T, Garcia-Sayre J, Yessaian AA, Roman LD. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy. Gynecol Oncol [Internet]. Academic Press Inc.; 2017 Apr 1 [cited 2025 Jun 4];145(1):41–9. Available from: https://pubmed.ncbi.nlm.nih.gov/28215841/

Uterine Neoplasms - Guidelines Detail [Internet]. [cited 2025 Jun 7]. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1473

Bestvina CM, Fleming GF. Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings. Oncologist [Internet]. Oxford University Press (OUP); 2016 Oct 1 [cited 2025 Jun 2];21(10):1250. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5061541/

Kalampokas E, Giannis G, Kalampokas T, Papathanasiou AA, Mitsopoulou D, Tsironi E, et al. Current Approaches to the Management of Patients with Endometrial Cancer. Cancers 2022, Vol 14, Page 4500 [Internet]. Multidisciplinary Digital Publishing Institute; 2022 Sep 16 [cited 2025 Jun 4];14(18):4500. Available from: https://www.mdpi.com/2072-6694/14/18/4500/htm

Chiang S, Soslow RA. Updates in diagnostic immunohistochemistry in endometrial carcinoma. Semin Diagn Pathol [Internet]. W.B. Saunders; 2014 [cited 2025 Jun 1];31(3):205–15. Available from: https://pubmed.ncbi.nlm.nih.gov/24951284/

Wang M, Hui P. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas. Arch Pathol Lab Med [Internet]. Allen Press; 2021 Nov 1 [cited 2025 Jun 1];145(11):1367–78. Available from: https://dx.doi.org/10.5858/arpa.2021-0098-RA

Favier A, Varinot J, Uzan C, Duval A, Brocheriou I, Canlorbe G. The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review. Cancers (Basel). MDPI; 2022 Aug 1;14(15)




DOI: http://dx.doi.org/10.24198/obgynia.v9i1.959

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


     
 

Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat